I will add to my previous comment that I have a feeling, nothing definitive, but a strong feeling that Javitt is pretty sure that when the full data analysis comes in the results will be evenbetter and will make a very powerful data based argument for Zysami.
Also the difference between this conference call and the last is that they were prepared. JJ obviously read a prepared statement which would have been vetted by the lawyers just like any business would do. In previous calls he was just speaking off the cuff which isn’t great for the technical guys to do, that’s why they got in trouble with the 28 day results. He got mired in jargon and technical details that we didn’t understand and people freaked out. This time they learned their lesson and had a clear and concise message. Also VERY early on JJ got his wrist slapped for saying things they couldn’t legally back up because he’s not a PR guy. They fixed that as well.
Random internet dude VS lifelong doctor and researcher with a long career at the fda plus a room full of lawyers and investigators. My money is on them.
News 
Market Data 
Discover 
AI
